Английская Википедия:FUBIMINA

Материал из Онлайн справочника
Версия от 04:14, 6 марта 2024; EducationBot (обсуждение | вклад) (Новая страница: «{{Английская Википедия/Панель перехода}} {{Short description|Chemical compound}} {{technical|date=June 2015}} {{Drugbox | IUPAC_name = (1-(5-fluoropentyl)-1''H''-benzo[''d'']imidazol-2-yl)(naphthalen-1-yl)methanone | image = FUBIMINA_structure.png <!--Clinical data--> | tradename = | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = Schedule II | legal_DE = NpSG | legal_UK = Class B | l...»)
(разн.) ← Предыдущая версия | Текущая версия (разн.) | Следующая версия → (разн.)
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Technical

Шаблон:Drugbox

FUBIMINA (also known as BIM-2201, BZ-2201 and FTHJ) is a synthetic cannabinoid that is the benzimidazole analog of AM-2201[1] and has been used as an active ingredient in synthetic cannabis products.[2] It was first identified in Japan in 2013, alongside MEPIRAPIM.[3]

FUBIMINA acts as a reasonably potent agonist for the CB2 receptor (Ki = 23.45 nM), with 12x selectivity over CB1 (Ki = 296.1 nM), and does not fully substitute for Δ9-THC in rat discrimination studies.[4]

Related benzimidazole derivatives have been reported to be highly selective agonists for the CB2 receptor.[5]

See also

References

Шаблон:Reflist

Шаблон:Cannabinoids

Шаблон:Cannabinoid-stub